Tuberculosis, Multidrug-Resistant
Showing 1 - 25 of 6,787
Strengthening Evidence on Optimal Multidrug-resistant
Recruiting
- Tuberculosis, Multidrug-Resistant
- HIV
- Bdq, Lzd, Lfx, Dlm, Cfz (9-12 months)
- +2 more
-
Almaty, Kazakhstan
- +2 more
May 12, 2023
Clinical Evaluation of tNGS for Diagnosis of DR-TB
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- targeted Next Generation Sequencing (tNGS)
-
Tbilisi, Georgia
- +2 more
Jan 23, 2023
Tuberculosis, Multidrug Resistant Tuberculosis Trial in Paris (Tedizolid arm (SIVEXTRO®), Linezolid arm (ZYVOXID®), Standard
Not yet recruiting
- Tuberculosis
- Multidrug Resistant Tuberculosis
- Tedizolid arm (SIVEXTRO®)
- +2 more
-
Paris, FranceBacteriology department- Hôpital Saint-Antoine
Sep 6, 2022
Multidrug-resistant Tuberculosis
Recruiting
- Multi-Drug Resistant Tuberculosis
-
Paris, FrancePitié Salpêtrière Hospital
Mar 28, 2022
Tuberculosis, Multidrug Resistant Trial in Chernivtsi, Ivano-Frankivs'k, Kharkiv (RUTI® Therapeutic vaccine, Matching RUTI®
Terminated
- Tuberculosis, Multidrug Resistant
- RUTI® Therapeutic vaccine
- Matching RUTI® Placebo
-
Chernivtsi, Ukraine
- +2 more
Jun 30, 2022
Tuberculosis, Thoracic Surgery, Tuberculosis, Pulmonary Trial in Tbilisi (therapeutical surgery for TB)
Active, not recruiting
- Tuberculosis
- +3 more
- therapeutical surgery for TB
-
Tbilisi, GeorgiaNational Center for Tuberculosis and Lung Diseases
Sep 9, 2022
Drug-resistant Tuberculosis, HIV Coinfection, Cost-Benefit Analysis Trial in Cape Town (Targeted next-generation sequencing)
Not yet recruiting
- Drug-resistant Tuberculosis
- +2 more
- Targeted next-generation sequencing
-
Cape Town, South AfricaSouth African National Health Laboratory Service
Sep 23, 2022
Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)
Recruiting
- Tuberculosis, Multidrug-Resistant
- Delamanid
- +4 more
-
Dasmariñas, Philippines
- +1 more
Jun 21, 2022
Pharmacometrics to Advance Novel Regimens for Drug-resistant
Recruiting
- Multi-drug Resistant Tuberculosis
-
Almaty, Kazakhstan
- +6 more
Nov 1, 2022
Drug Resistant Tuberculosis Trial (Nurse-Led Treatment in Primary Care)
Not yet recruiting
- Drug Resistant Tuberculosis
- Nurse-Led Treatment in Primary Care
- (no location specified)
Dec 20, 2022
Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Bedaquiline
- +7 more
-
Tbilisi, Georgia
- +11 more
Feb 14, 2022
Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG
Recruiting
- Tuberculosis, Multidrug-Resistant
- +5 more
- Bedaquiline 100 MG
- +4 more
-
Pune, India
- +9 more
Mar 2, 2022
Bioneer Accupower Q-RFIA PCR Kit Clinical Evaluation
Recruiting
- Tuberculosis, Multidrug-Resistant
-
Nairobi, Kenya
- +2 more
Mar 16, 2022
Tuberculosis, Multidrug-Resistant Trial in Cape Town (Targeted sequencing using the GenoScreen Deeplex assay)
Not yet recruiting
- Tuberculosis, Multidrug-Resistant
- Targeted sequencing using the GenoScreen Deeplex assay
-
Cape Town, Western Cape, South AfricaUniversity of Cape Town
Sep 28, 2021
Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid
Active, not recruiting
- Tuberculosis
- +4 more
- Bedaquiline Oral Tablet
- +7 more
-
Port Elizabeth, Eastern Cape, South Africa
- +1 more
Oct 20, 2022
Tuberculosis Trial in Ogre, Siauliai, Vilnius (Delamanid, Optimized Background Regimen (OBR))
Terminated
- Tuberculosis
- Delamanid
- Optimized Background Regimen (OBR)
-
Ogre, Latvia
- +2 more
Oct 14, 2021
Rifampicin Resistant Tuberculosis, Drug-resistant Tuberculosis, Multidrug Resistant Tuberculosis Trial in Bloemfontein (WGS DST
Recruiting
- Rifampicin Resistant Tuberculosis
- +3 more
- WGS DST strategy
-
Bloemfontein, Free State, South AfricaFree State Department of Health Clinics
Oct 14, 2021
Expand New Drugs for TB [endTB]
Completed
- Tuberculosis, Multidrug-Resistant
- This is a non-intervention observational study
-
Abovyan, Armenia
- +15 more
Jun 9, 2022
Hotspots, Households and Hospitals: Enhanced Drug-resistant
Not yet recruiting
- Tuberculosis, Multidrug-Resistant
- (no location specified)
Aug 19, 2021
Tuberculosis, MDR Trial in Kazakhstan, Kyrgyzstan (FS-1, Placebo)
Completed
- Tuberculosis, MDR
- FS-1
- Placebo
-
Semey, East-Kazakhstan Region, Kazakhstan
- +5 more
May 17, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, Extensively Drug-Resistant Tuberculosis Trial in Worldwide
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg
Recruiting
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +3 more
-
Johannesburg, South Africa
- +2 more
Oct 4, 2021